Drug Sponsors

Denali Therapeutics launches to study neurodegenerative disease treatments

Friday, May 15, 2015

Denali Therapeutics, a new California-based biotechnology company focused on developing effective therapies for neurodegenerative diseases, has launched with an initial investment commitment of $217 million. Denali is based on the collaboration of world-class scientists, industry experts and investors. Recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.

[Read More]

California Life Sciences Association launches, following BayBio, California Healthcare Institute merger

Friday, May 15, 2015

The California Life Sciences Association (CLSA) has officially launched as a representation for California’s life sciences sector. CLSA now is the largest state and regional life sciences advocacy group in the country, with more than 750 members. The organization advances California’s life sciences innovation ecosystem by advocating for effective national, state and local public policies and supporting entrepreneurs and life sciences businesses. CLSA is the result of a completed merger between BayBio and California Healthcare Institute.

[Read More]